Skip to main content
Top
Published in: Infection 2/2013

01-04-2013 | Clinical and Epidemiological Study

Compliance with antimalarial chemoprophylaxis in German soldiers: a 6-year survey

Authors: H. Frickmann, N. G. Schwarz, H.-U. Holtherm, W. Maaßen, F. Vorderwülbecke, K. Erkens, M. Fischer, T. Morwinsky, R. M. Hagen

Published in: Infection | Issue 2/2013

Login to get access

Abstract

Purpose

Since 1992, German soldiers have been deployed in areas where malaria is endemic. Antimalarial chemoprophylaxis (CP) is directed according to the assessed risk and is provided free of charge. Compliance is crucial if its effect is to be reliable. This study analysed compliance with directed CP in German soldiers as well as its determinants.

Methods

Between 2003 and 2009, standardized questionnaire-based interviews were performed with 2,149 out of approximately 100,000 German soldiers who were deployed during this period in areas where malaria is endemic. The questionnaires dealt with information that the soldiers had received about malaria prior to their missions, with their adherence to mosquito-protective and antimalarial chemoprophylactic procedures, and their estimations of their individual level of exposure.

Results

About 1,308 out of 2,149 interviewed soldiers had been ordered to take CP, allowing for an assessment of the outcome parameter “CP-compliance”. About 76.9 % out of 1,308 soldiers to whom regular CP was directed took it regularly. The exposure variables “age”, “satisfaction with malaria counselling”, “perceived threat due to insects or mosquitoes” and “use of insect repellents” were positively associated with compliance with directed antimalarial CP.

Conclusions

The study confirms the findings of the French and US armies that even free-of-charge access to antimalarial medication will not lead to 100 % acceptance. The compliance problem is aggravated by the generally low age of deployed soldiers. Adequate counselling is crucial to increase adherence to antimalarial CP.
Literature
1.
go back to reference Rey S, Zuza I, Martinez-Mondejar B, Rubio JM, Merino FJ. Imported malaria in an area in southern Madrid, 2005–2008. Malar J. 2010;9:290.PubMedCrossRef Rey S, Zuza I, Martinez-Mondejar B, Rubio JM, Merino FJ. Imported malaria in an area in southern Madrid, 2005–2008. Malar J. 2010;9:290.PubMedCrossRef
2.
go back to reference Bueno Mari R, Jimenez Peydro R. Pueden la malaria y el dengue reaparecer en Espana? Gac Sanit. 2010;24:347–53. Bueno Mari R, Jimenez Peydro R. Pueden la malaria y el dengue reaparecer en Espana? Gac Sanit. 2010;24:347–53.
3.
go back to reference Santa-Olalla Peralta P, Vazquez-Torres MC, Latorre-Fandos E, Mairal-Claver P, Cortina-Solano P, Puy-Azon A, Adiego Sancho B, Leitmeyer K, Lucientes-Curdi J, Sierra-Moros MJ. First autochthonous malaria case due to Plasmodium vivax since eradication, Spain, October 2010. Euro Surveill. 2010;15:19684. Santa-Olalla Peralta P, Vazquez-Torres MC, Latorre-Fandos E, Mairal-Claver P, Cortina-Solano P, Puy-Azon A, Adiego Sancho B, Leitmeyer K, Lucientes-Curdi J, Sierra-Moros MJ. First autochthonous malaria case due to Plasmodium vivax since eradication, Spain, October 2010. Euro Surveill. 2010;15:19684.
4.
go back to reference Schoneberg I, Stark K, Altmann D, Krause G. [Malaria in Germany 1993 to 2003. Data from the Robert Koch Institute on affected groups of people, countries traveled to and treatment]. Dtsch Med Wochenschr. 2005;130:937–41. Schoneberg I, Stark K, Altmann D, Krause G. [Malaria in Germany 1993 to 2003. Data from the Robert Koch Institute on affected groups of people, countries traveled to and treatment]. Dtsch Med Wochenschr. 2005;130:937–41.
5.
go back to reference van Rijckevorsel GG, Sonder GJ, Geskus RB, Wetsteyn JC, Ligthelm RJ, Visser LG, Keuter M, van Genderen PJ, van den Hoek A. Declining incidence of imported malaria in the Netherlands, 2000–2007. Malar J. 2010;9:300.PubMedCrossRef van Rijckevorsel GG, Sonder GJ, Geskus RB, Wetsteyn JC, Ligthelm RJ, Visser LG, Keuter M, van Genderen PJ, van den Hoek A. Declining incidence of imported malaria in the Netherlands, 2000–2007. Malar J. 2010;9:300.PubMedCrossRef
6.
go back to reference Bruneel F, Tubach F, Corne P, Megarbane B, Mira JP, Peytel E, Camus C, Schortgen F, Azoulay E, Cohen Y, Georges H, Meybeck A, Hyvernat H, Trouillet JL, Frenoy E, Nicolet L, Roy C, Durand R, Le Bras J, Wolff M, Severe Imported Malaria in Adults (SIMA) Study Group. Severe imported falciparum malaria: a cohort study in 400 critically ill adults. PLoS ONE. 2010;5:e13236.PubMedCrossRef Bruneel F, Tubach F, Corne P, Megarbane B, Mira JP, Peytel E, Camus C, Schortgen F, Azoulay E, Cohen Y, Georges H, Meybeck A, Hyvernat H, Trouillet JL, Frenoy E, Nicolet L, Roy C, Durand R, Le Bras J, Wolff M, Severe Imported Malaria in Adults (SIMA) Study Group. Severe imported falciparum malaria: a cohort study in 400 critically ill adults. PLoS ONE. 2010;5:e13236.PubMedCrossRef
7.
go back to reference Widmer LL, Blank PR, Van Herck K, Hatz C, Schlagenhauf P. Cost-effectiveness analysis of malaria chemoprophylaxis for travellers to West-Africa. BMC Infect Dis. 2010;10:279.PubMedCrossRef Widmer LL, Blank PR, Van Herck K, Hatz C, Schlagenhauf P. Cost-effectiveness analysis of malaria chemoprophylaxis for travellers to West-Africa. BMC Infect Dis. 2010;10:279.PubMedCrossRef
8.
go back to reference Krause G, Schoneberg I, Altmann D, Stark K. Chemoprophylaxis and malaria death rates. Emerg Infect Dis. 2006;12:447–51.PubMedCrossRef Krause G, Schoneberg I, Altmann D, Stark K. Chemoprophylaxis and malaria death rates. Emerg Infect Dis. 2006;12:447–51.PubMedCrossRef
10.
go back to reference Legros F, Bouchaud O, Ancelle T, Arnaud A, Cojean S, Le Bras J, Danis M, Fontanet A, Durand R. Risk factors for imported fatal Plasmodium falciparum malaria, France, 1996–2003. Emerg Infect Dis. 2007;13:883–8.PubMedCrossRef Legros F, Bouchaud O, Ancelle T, Arnaud A, Cojean S, Le Bras J, Danis M, Fontanet A, Durand R. Risk factors for imported fatal Plasmodium falciparum malaria, France, 1996–2003. Emerg Infect Dis. 2007;13:883–8.PubMedCrossRef
11.
go back to reference Croft AM, Garner P. Mefloquine for preventing malaria in non-immune adult travellers. Cochrane Database Syst Rev. 2000;4:CD000138. Croft AM, Garner P. Mefloquine for preventing malaria in non-immune adult travellers. Cochrane Database Syst Rev. 2000;4:CD000138.
12.
go back to reference Hopperus Buma AP, van Thiel PP, Lobel HO, Ohrt C, van Ameijden EJ, Veltink RL, Tendeloo DC, van Gool T, Green MD, Todd GD, Kyle DE, Kager PA. Long-term malaria chemoprophylaxis with mefloquine in Dutch marines in Cambodia. J Infect Dis. 1996;173:1506–9. Hopperus Buma AP, van Thiel PP, Lobel HO, Ohrt C, van Ameijden EJ, Veltink RL, Tendeloo DC, van Gool T, Green MD, Todd GD, Kyle DE, Kager PA. Long-term malaria chemoprophylaxis with mefloquine in Dutch marines in Cambodia. J Infect Dis. 1996;173:1506–9.
13.
go back to reference Schlagenhauf P, Adamcova M, Regep L, Schaerer MT, Rhein HG. The position of mefloquine as a 21st century malaria chemoprophylaxis. Malar J. 2010;9:357.PubMedCrossRef Schlagenhauf P, Adamcova M, Regep L, Schaerer MT, Rhein HG. The position of mefloquine as a 21st century malaria chemoprophylaxis. Malar J. 2010;9:357.PubMedCrossRef
14.
go back to reference Nakato H, Vivancos R, Hunter PR. A systematic review and meta-analysis of the effectiveness and safety of atovaquone proguanil (Malarone) for chemoprophylaxis against malaria. J Antimicrob Chemother. 2007;60:929–36.PubMedCrossRef Nakato H, Vivancos R, Hunter PR. A systematic review and meta-analysis of the effectiveness and safety of atovaquone proguanil (Malarone) for chemoprophylaxis against malaria. J Antimicrob Chemother. 2007;60:929–36.PubMedCrossRef
15.
go back to reference Overbosch D, Schilthuis H, Bienzle U, Behrens RH, Kain KC, Clarke PD, Toovey S, Knobloch J, Nothdurft HD, Shaw D, Roskell NS. Malarone International Study Team. Atovaquone-proguanil versus mefloquine for malaria prophylaxis in nonimmune travelers: results from a randomized, double-blind study. Clin Infect Dis. 2001;33:1015–21.PubMedCrossRef Overbosch D, Schilthuis H, Bienzle U, Behrens RH, Kain KC, Clarke PD, Toovey S, Knobloch J, Nothdurft HD, Shaw D, Roskell NS. Malarone International Study Team. Atovaquone-proguanil versus mefloquine for malaria prophylaxis in nonimmune travelers: results from a randomized, double-blind study. Clin Infect Dis. 2001;33:1015–21.PubMedCrossRef
16.
go back to reference Sonmez A, Harlak A, Kilic S, Polat Z, Hayat L, Keskin O, Dogru T, Yilmaz MI, Acikel CH, Kocar IH. The efficacy and tolerability of doxycycline and mefloquine in malaria prophylaxis of the ISAF troops in Afghanistan. J Infect. 2005;51:253–8.PubMedCrossRef Sonmez A, Harlak A, Kilic S, Polat Z, Hayat L, Keskin O, Dogru T, Yilmaz MI, Acikel CH, Kocar IH. The efficacy and tolerability of doxycycline and mefloquine in malaria prophylaxis of the ISAF troops in Afghanistan. J Infect. 2005;51:253–8.PubMedCrossRef
17.
go back to reference Whitman TJ, Coyne PE, Magill AJ, Blazes DL, Green MD, Milhous WK, Burgess TH, Freilich D, Tasker SA, Azar RG, Endy TP, Clagett CD, Deye GA, Shanks GD, Martin GJ. An outbreak of Plasmodium falciparum malaria in US marines deployed to Liberia. Am J Trop Med Hyg. 2010;83:258–65.PubMedCrossRef Whitman TJ, Coyne PE, Magill AJ, Blazes DL, Green MD, Milhous WK, Burgess TH, Freilich D, Tasker SA, Azar RG, Endy TP, Clagett CD, Deye GA, Shanks GD, Martin GJ. An outbreak of Plasmodium falciparum malaria in US marines deployed to Liberia. Am J Trop Med Hyg. 2010;83:258–65.PubMedCrossRef
18.
go back to reference Bellanger AP, Faucher JF, Robedat P, Schmitt A, Millon L, Hoen B. Malaria outbreak in French troops returning from Côte d’Ivoire. Scand J Infect Dis. 2011;43:230–3.PubMedCrossRef Bellanger AP, Faucher JF, Robedat P, Schmitt A, Millon L, Hoen B. Malaria outbreak in French troops returning from Côte d’Ivoire. Scand J Infect Dis. 2011;43:230–3.PubMedCrossRef
19.
go back to reference Hagen RM, Fischer M, Bronnert J, Wiemer D, Krueger A, Harbaum T. Medical support during EUFOR DR Congo: In-theatre experience and follow-up, first results. 5th ECTMIH. 2007;O28–12. Hagen RM, Fischer M, Bronnert J, Wiemer D, Krueger A, Harbaum T. Medical support during EUFOR DR Congo: In-theatre experience and follow-up, first results. 5th ECTMIH. 2007;O28–12.
20.
go back to reference Faulde MK, Heyl G, Amirih ML. Zoonotic cutaneus leishmaniasis, Afghanistan. Emerg Infect Dis. 2006;12:1623–4.PubMedCrossRef Faulde MK, Heyl G, Amirih ML. Zoonotic cutaneus leishmaniasis, Afghanistan. Emerg Infect Dis. 2006;12:1623–4.PubMedCrossRef
21.
go back to reference Alon D, Shitrit P, Chowers M. Risk behaviors and spectrum of diseases among elderly travelers: a comparison of younger and older adults. J Travel Med. 2010;17:250–5.PubMedCrossRef Alon D, Shitrit P, Chowers M. Risk behaviors and spectrum of diseases among elderly travelers: a comparison of younger and older adults. J Travel Med. 2010;17:250–5.PubMedCrossRef
22.
go back to reference Pistone T, Ezzedine K, Gaudin AF, Hercberg S, Nachbaur G, Malvy D. Malaria prevention behaviour and risk awareness in French adult travellers. Travel Med Infect Dis. 2010;8:13–21.PubMedCrossRef Pistone T, Ezzedine K, Gaudin AF, Hercberg S, Nachbaur G, Malvy D. Malaria prevention behaviour and risk awareness in French adult travellers. Travel Med Infect Dis. 2010;8:13–21.PubMedCrossRef
23.
go back to reference Ropers G, Du Ry van Beest Holle M, Wichmann O, Kappelmayer L, Stuben U, Schonfeld C, Stark K. Determinants of malaria prophylaxis among German travelers to Kenya, Senegal, and Thailand. J Travel Med. 2008;15:162–71.PubMedCrossRef Ropers G, Du Ry van Beest Holle M, Wichmann O, Kappelmayer L, Stuben U, Schonfeld C, Stark K. Determinants of malaria prophylaxis among German travelers to Kenya, Senegal, and Thailand. J Travel Med. 2008;15:162–71.PubMedCrossRef
24.
go back to reference Mayet A, Lacassagne D, Juzan N, Chaudier B, Haus-Cheymol R, Berger F, Romand O, Ollivier L, Verret C, Deparis X, Spiegel A. Malaria outbreak among French army troops returning from the Ivory Coast. J Travel Med. 2010;17:353–5.PubMedCrossRef Mayet A, Lacassagne D, Juzan N, Chaudier B, Haus-Cheymol R, Berger F, Romand O, Ollivier L, Verret C, Deparis X, Spiegel A. Malaria outbreak among French army troops returning from the Ivory Coast. J Travel Med. 2010;17:353–5.PubMedCrossRef
25.
go back to reference Kotwal RS, Wenzel RB, Sterling RA, Porter WD, Jordan NN, Petruccelli BP. An outbreak of malaria in US army rangers returning from Afghanistan. JAMA. 2005;293:212–6.PubMedCrossRef Kotwal RS, Wenzel RB, Sterling RA, Porter WD, Jordan NN, Petruccelli BP. An outbreak of malaria in US army rangers returning from Afghanistan. JAMA. 2005;293:212–6.PubMedCrossRef
26.
go back to reference Andersson H, Askling HH, Falck B, Rombo L. Well-tolerated chemoprophylaxis uniformly prevented Swedish soldiers from Plasmodium falciparum malaria in Liberia, 2004–2006. Mil Med. 2008;173:1194–8.PubMed Andersson H, Askling HH, Falck B, Rombo L. Well-tolerated chemoprophylaxis uniformly prevented Swedish soldiers from Plasmodium falciparum malaria in Liberia, 2004–2006. Mil Med. 2008;173:1194–8.PubMed
27.
go back to reference Resseguier N, Machault V, Ollivier L, Orlandi-Pradines E, Texier G, Pradines B, Gaudart J, Buguet A, Tourette-Turgis C, Rogier C. Determinants of compliance with malaria chemoprophylaxis among French soldiers during missions in inter-tropical Africa. Malar J. 2010;9:41.PubMedCrossRef Resseguier N, Machault V, Ollivier L, Orlandi-Pradines E, Texier G, Pradines B, Gaudart J, Buguet A, Tourette-Turgis C, Rogier C. Determinants of compliance with malaria chemoprophylaxis among French soldiers during missions in inter-tropical Africa. Malar J. 2010;9:41.PubMedCrossRef
28.
go back to reference Ollivier L, Michel R, Carlotti MP, Mahe P, Romand O, Todesco A, Migliani R, Boutin JP. Chemoprophylaxis compliance in a French battalion after returning from malaria-endemic area. J Travel Med. 2008;15:355–7.PubMedCrossRef Ollivier L, Michel R, Carlotti MP, Mahe P, Romand O, Todesco A, Migliani R, Boutin JP. Chemoprophylaxis compliance in a French battalion after returning from malaria-endemic area. J Travel Med. 2008;15:355–7.PubMedCrossRef
Metadata
Title
Compliance with antimalarial chemoprophylaxis in German soldiers: a 6-year survey
Authors
H. Frickmann
N. G. Schwarz
H.-U. Holtherm
W. Maaßen
F. Vorderwülbecke
K. Erkens
M. Fischer
T. Morwinsky
R. M. Hagen
Publication date
01-04-2013
Publisher
Springer-Verlag
Published in
Infection / Issue 2/2013
Print ISSN: 0300-8126
Electronic ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-013-0411-5

Other articles of this Issue 2/2013

Infection 2/2013 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.